Glucose Intake and Utilization in Pre-Diabetes and Diabetes

Ronald R. Watson, Ph.D., attended the University of Idaho but graduated from Brigham Young University in Provo, Utah, with a degree in chemistry in 1966. He earned his Ph.D. in biochemistry from Michigan State University in 1971. His postdoctoral schooling in nutrition and microbiology was completed at the Harvard School of Public Health, where he gained 2 years of postdoctoral research experience in immunology and nutrition. From 1973 to 1974 Dr. Watson was assistant professor of immunology and performed research at the University of Mississippi Medical Center in Jackson. He was assistant professor of microbiology and immunology at the Indiana University Medical School from 1974 to 1978 and associate professor at Purdue University in the Department of Food and Nutrition from 1978 to 1982. In 1982 Dr. Watson joined the faculty at the University of Arizona Health Sciences Center in the Department of Family and Community Medicine of the School of Medicine. He is currently professor of health promotion sciences in the Mel and Enid Zuckerman Arizona College of Public Health. Dr. Watson is a member of several national and international nutrition, immunology, cancer, and alcoholism research societies. Among his patents he has one on a dietary supplement; passion fruit peel extract with more pending. He continues to do research in animals and in clinical trials on dietary supplements and health including studies using omega-3 fatty acids in heart disease prevention and therapy. For 30 years he was funded by Wallace Research Foundation to study dietary supplements in health promotion. Dr. Watson has edited more than 110 books on nutrition, dietary supplements and over-the-counter agents, and drugs of abuse as scientific reference books. He has published more than 500 research and review articles. Dr. Betsy Dokken has training and degrees in nursing. Her Ph.D. is in experimental diabetes in rats working on insulin resistance. Her postdoctoral fellowship was at the applied Cardiovascular Physiology Laboratories in the University of Arizona Sarver Heart Center. She studied ischemia-reperfusion injury in diabetic hearts. Betsy is a certified diabetic educator and registered nurse. Dr. Dokken is an adjunct clinical assistant professor of nursing. Her principal appointment is in the section of Endocrinology, Diabetes and Hypertension with 20% of her time spent on clinical practice (diabetes, obesity, and related disorders). She has published 7 review chapters, 13 peer reviewed chapters and 10 journal articles relating to CVD and diabetes. Her grants and research focus on diabetic heart disease. Betsy has been extensively involved in nursing and diabetes societies in Arizona and nationally.

This important reference, edited by Ronald Ross Watson and Betsy Dokken, collects the research needed to make the distinct connection between pre-diabetes, diabetes, and cardiovascular disease. Glucose Intake and Utilization in Pre-Diabetes and Diabetes: Implications for Cardiovascular Disease explains the mechanisms of progression from pre-diabetes to diabetes to cardiovascular disease. Since pre-diabetes and diabetes are important cardiovascular disease risk factors, and impaired glucose metabolism among cardiac patients is extremely prevalent, the importance of reviewing pre-diabetes and its involvement in CVD complications is vital as one applies food and glycemic control to slow progress to diabetes and heart disease. The book further focuses on glucose intake and utilization in diabetes, including coverage of diabetes in the development and pathology of cardiovascular disease, risks and epidemiology of cardiovascular problems promoted by diabetes, macrovascular effects and their safety in therapy of diabetics, beta cell biology and therapy of diabetes, and nutrition to modulate diabetes.

1: Early origins of health and disease 2: Diabetes and obesity: The impact of their coincidence on health and life 3: Diabetes:  A new horizon and approach to management4: Psychosocial Factors Associated with Diabetes Self-Management 5: The relationship between the organization of services for the treatment of type 2 diabetes and the risk of long-term complications 6: Effects of Bariatric surgery on co-morbid conditions associated with morbid obesity 7: Dietary and  management of type 2 diabetes 8: Insulin Resistance and Inflammation, Links between Obesity and Cardiovascular Disease 9: Cardiovascular risk assessment in prediabetes: A hypothesis10: Pre-diabetes, cardiovascular risk factors, arterial stiffness-ADMA 11: Effect of fiber and low glycemic load diet on blood glucose profile and cardiovascular risk factors in diabetes and poorly-controlled diabetic subjects 12: Glucose uptake and its consequence on cardiomyocyte function 13: Hypertension and Dyslipidemia in patients with prediabetes: dietary and other therapies? 14: Animal Models of Diabetic Cardiomyopathy 15: 4-Hydroxyisoleucine-Potential antidiabetic agent from Trigonella foenum graecum 16: mHealth Technologies in Pre-Diabetes and Diabetes Care17: Fruit and glycemic control in type 2 diabetes18: Antihyperglycemic activity of bioactive compounds from soybeans 19: Myoinositol supplementation on insulin resistance in gestational diabetes20: The Tibetan herbal preparation Padma 28 (Padma basic) in treatment and prevention of diabetic complications and atherosclerosis 21: Cardiovascular Biomarker Assessment Across Glycemic Status 22: The transcultural diabetes nutritional algorithm (tDNA): from concept to implementation 23: Microcirculation: a key effector in insulin resistance24: Glucose intake and utilization in pre-diabetes and diabetes:  Tomato and diabetes  25: Optimal  carbohydrate and nutrient intake for Japanese elderly patients with type 2 diabetes 26: Mediterranean diet for  prevention of diabetes and cardiovascular disease and type 2 diabetes      27: Role of food and supplements in health of dialysis patients 28: Bioactive compounds increased incretins with beneficial effects on diabetes 29: Exercise and diet improve cardiometabolic risk in overweight and obese individuals without weight loss 30: Protein in the treatment of type 2 diabetes mellitus 31: Nutritional support in hospitalized patients with diabetes mellitus 32: Amino acids supplementation as nutritional therapy